SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-018082
Filing Date
2023-05-18
Accepted
2023-05-18 15:24:28
Documents
14
Period of Report
2023-05-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38755
2 ex99-1.htm EX-99.1 11943
3 ex99-1_1.jpg GRAPHIC 6938
  Complete submission text file 0001493152-23-018082.txt   238453

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pcsa-20230518.xsd EX-101.SCH 3272
5 XBRL LABEL FILE pcsa-20230518_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE pcsa-20230518_pre.xml EX-101.PRE 22389
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3611
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 23935816
SIC: 2834 Pharmaceutical Preparations